Biologics and cell therapy programs are under increasing pressure to deliver high‑quality cell lines and physiologically meaningful 3D models—faster, more consistently, and with full traceability. Yet ...
Explore SLAS Boston 2026 insights on connecting laboratory automation and data infrastructure in drug discovery workflows.
Biocomputing is transitioning to deployment, shifting from research to real-world use in healthcare and industrial biotechnology. Key opportunities include DNA and RNA computing for data storage and ...
OpenAI co-founder Greg Brockman discusses the transition to fully robotic wet labs and massive-scale automated experiments with venture capitalist Vinod Khosla.
Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will be featured in HighRes’ Lightning Talk at the NVIDIA GTC AI ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results